BR112012030818A2 - "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv" - Google Patents
"derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv"Info
- Publication number
- BR112012030818A2 BR112012030818A2 BR112012030818A BR112012030818A BR112012030818A2 BR 112012030818 A2 BR112012030818 A2 BR 112012030818A2 BR 112012030818 A BR112012030818 A BR 112012030818A BR 112012030818 A BR112012030818 A BR 112012030818A BR 112012030818 A2 BR112012030818 A2 BR 112012030818A2
- Authority
- BR
- Brazil
- Prior art keywords
- inhibitors
- modified
- betulinic acid
- acid derivatives
- hiv maturation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Abstract
derivados de ácido c-3 betulínico modificado inibidores da maturação do hiv. compostos tendo propriedades medicamentosas e que podem afetar biologia, suas composições farmacêuticas e métodos de uso são apresentados. em particular, ácido c-3 betulínico modificado e outros derivados de produtos naturais estruturalmente relacionados que possuem atividade antiviral ímpar são fornecidos como inibidores da maturação do hiv. esses compostos são úteis para o tratamento de hiv e aids.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35133810P | 2010-06-04 | 2010-06-04 | |
PCT/US2011/038879 WO2011153315A1 (en) | 2010-06-04 | 2011-06-02 | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012030818A2 true BR112012030818A2 (pt) | 2019-09-24 |
Family
ID=44627236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012030818A BR112012030818A2 (pt) | 2010-06-04 | 2011-06-02 | "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv" |
Country Status (12)
Country | Link |
---|---|
US (1) | US8754068B2 (pt) |
EP (1) | EP2576585B8 (pt) |
JP (1) | JP5752789B2 (pt) |
CN (1) | CN103038245B (pt) |
AR (1) | AR081637A1 (pt) |
BR (1) | BR112012030818A2 (pt) |
CA (1) | CA2801487C (pt) |
EA (1) | EA022393B1 (pt) |
ES (1) | ES2612452T3 (pt) |
MX (1) | MX2012013703A (pt) |
TW (1) | TW201201793A (pt) |
WO (1) | WO2011153315A1 (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11090313B2 (en) | 2010-05-20 | 2021-08-17 | University Of Iowa Research Foundation | Methods for inhibiting muscle atrophy |
AU2011255495A1 (en) | 2010-05-20 | 2012-12-06 | The United States Of America, As Represented By The Secretary Of The Department Of Veterans Affairs | Methods for inhibiting muscle atrophy |
KR101886467B1 (ko) * | 2011-01-31 | 2018-08-07 | 비브 헬스케어 유케이 (넘버4) 리미티드 | Hiv 성숙 억제 활성을 갖는 c-17 및 c-3 변형 트리테르페노이드 |
EP2670764B1 (en) * | 2011-01-31 | 2015-09-02 | Bristol-Myers Squibb Company | C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors |
JP6001060B2 (ja) | 2011-06-06 | 2016-10-05 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 筋萎縮を阻害するための方法 |
AU2012312485B2 (en) | 2011-09-21 | 2016-09-01 | VIIV Healthcare UK (No.5) Limited | Novel betulinic acid derivatives with antiviral activity |
US8906889B2 (en) * | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
WO2014105926A1 (en) | 2012-12-31 | 2014-07-03 | Hetero Research Foundation | Novel betulinic acid proline derivatives as hiv inhibitors |
EP2953960A1 (en) * | 2013-02-06 | 2015-12-16 | Bristol-Myers Squibb Company | C-19 modified triterpenoids with hiv maturation inhibitory activity |
BR112015019590A2 (pt) | 2013-02-25 | 2017-07-18 | Bristol Myers Squibb Co | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv |
AR101077A1 (es) | 2014-04-11 | 2016-11-23 | Bristol Myers Squibb Co | Triterpenoides con actividad inhibidora de la maduración de hiv |
WO2015195776A1 (en) | 2014-06-19 | 2015-12-23 | Bristol-Myers Squibb Company | Betulinic acid derivatives with hiv maturation inhibitory activity |
US20170129916A1 (en) | 2014-06-26 | 2017-05-11 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
KR20170092580A (ko) * | 2014-11-14 | 2017-08-11 | 비브 헬스케어 유케이 (넘버5) 리미티드 | 연장된 베툴린산 유사체 |
CA2967679A1 (en) | 2014-11-14 | 2016-05-19 | VIIV Healthcare UK (No.5) Limited | Oxolupene derivatives |
KR20170092581A (ko) | 2014-11-14 | 2017-08-11 | 비브 헬스케어 유케이 (넘버5) 리미티드 | C17-아릴 치환된 베툴린산 유사체 |
MA40886B1 (fr) | 2015-02-09 | 2020-03-31 | Hetero Research Foundation | Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih |
WO2016147099A2 (en) | 2015-03-16 | 2016-09-22 | Hetero Research Foundation | C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors |
CN108026140A (zh) | 2015-07-28 | 2018-05-11 | 葛兰素史克知识产权第二有限公司 | 用于预防或治疗hiv感染的白桦脂醇衍生物 |
BR112018001537A2 (pt) | 2015-07-28 | 2018-09-18 | Glaxosmithkline Ip No 2 Ltd | composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para tratamento e para prevenção de uma infecção por hiv em um indivíduo, e, uso de um composto ou sal |
KR20180054826A (ko) | 2015-09-24 | 2018-05-24 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | Hiv 성숙 억제 활성을 갖는 화합물 |
CN108699103A (zh) | 2016-01-20 | 2018-10-23 | 葛兰素史克知识产权第二有限公司 | 具有hiv成熟抑制活性的羽扇烷类的胺衍生物 |
AR107512A1 (es) | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
WO2018002848A1 (en) * | 2016-06-30 | 2018-01-04 | VIIV Healthcare UK (No.5) Limited | Azadecalin derivatives as inhibitors of human immunodeficiency virus replication |
WO2018002849A1 (en) * | 2016-06-30 | 2018-01-04 | VIIV Healthcare UK (No.5) Limited | Triterpenoid inhibitors of human immunodeficiency virus replication |
EP3478661A1 (en) * | 2016-06-30 | 2019-05-08 | ViiV Healthcare UK (No.5) Limited | Aza-substituted inhibitors of human immunodeficiency virus replication |
US20210347813A1 (en) | 2018-04-24 | 2021-11-11 | Viiv Healthcare Uk (No. 5) Limited | Compounds with hiv maturation inhibitory activity |
PL237998B1 (pl) | 2018-05-28 | 2021-06-28 | Narodowy Inst Lekow | Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
US5962527A (en) | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
US5869535A (en) | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
US5679828A (en) * | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
DE69934486T2 (de) | 1998-03-02 | 2007-10-04 | The University Of North Carolina At Chapel Hill Office Of Technology Development | Acylierte betulin- und dihydrobetulinderivate, ihre herstellung und verwendung |
US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
JP2006504704A (ja) * | 2002-09-26 | 2006-02-09 | パナコス ファーマシューティカルズ, インコーポレイテッド | モノアシル化ベツリンおよびジヒドロベツリン誘導体、その製造および使用 |
US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
CN100432094C (zh) * | 2003-02-11 | 2008-11-12 | 诺瓦利克斯制药公司 | 抑制肿瘤生长的药物 |
US20050014730A1 (en) | 2003-04-02 | 2005-01-20 | Carlson Robert M. | Anti-fungal formulation of triterpene and essential oil |
US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
RU2387665C2 (ru) | 2004-03-17 | 2010-04-27 | Панакос Фармасьютикалз, Инк. | Фармацевтические соли 3-о-(3', 3'-диметилсукцинил)бетулиновой кислоты |
US20060019934A1 (en) * | 2004-05-20 | 2006-01-26 | Saxena Brij B | Anti-HIV-1 activity of betulinol derivatives |
TW200628161A (en) * | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
WO2007098247A2 (en) * | 2006-02-21 | 2007-08-30 | Achillion Pharmaceuticals, Inc. | Substituted taraxastanes useful for treating viral infections |
WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
US20090105203A1 (en) * | 2006-10-16 | 2009-04-23 | Myriad Genetics, Incorporated | Compounds for treating viral infections |
WO2009020732A1 (en) * | 2007-08-03 | 2009-02-12 | Advanced Life Sciences, Inc. | Lupane-type triterpenoids modified at 30-position and analogues thereof |
WO2009042166A1 (en) | 2007-09-25 | 2009-04-02 | Panacos Pharmaceuticals, Inc. | Liquid bevirimat dosage forms for oral administration |
WO2009100532A1 (en) | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | NOVEL 17ß LUPANE DERIVATIVES |
WO2009114083A2 (en) | 2008-03-03 | 2009-09-17 | Panacos Pharmaceuticals, Inc. | Determinants of antiviral response |
BRPI0911422B8 (pt) * | 2008-04-18 | 2021-05-25 | Reata Pharmaceuticals Inc | compostos moduladores inflamatórios antioxidantes, composição farmacêutica e usos dos mesmos |
MX2012009319A (es) * | 2010-02-11 | 2012-09-12 | Glaxosmithkline Llc | Derivados de betulina. |
-
2011
- 2011-06-02 WO PCT/US2011/038879 patent/WO2011153315A1/en active Application Filing
- 2011-06-02 EP EP11726563.7A patent/EP2576585B8/en not_active Not-in-force
- 2011-06-02 EA EA201270780A patent/EA022393B1/ru not_active IP Right Cessation
- 2011-06-02 ES ES11726563.7T patent/ES2612452T3/es active Active
- 2011-06-02 US US13/151,706 patent/US8754068B2/en not_active Expired - Fee Related
- 2011-06-02 CA CA2801487A patent/CA2801487C/en not_active Expired - Fee Related
- 2011-06-02 MX MX2012013703A patent/MX2012013703A/es active IP Right Grant
- 2011-06-02 BR BR112012030818A patent/BR112012030818A2/pt not_active IP Right Cessation
- 2011-06-02 CN CN201180038211.9A patent/CN103038245B/zh not_active Expired - Fee Related
- 2011-06-02 JP JP2013513339A patent/JP5752789B2/ja not_active Expired - Fee Related
- 2011-06-03 TW TW100119644A patent/TW201201793A/zh unknown
- 2011-06-03 AR ARP110101944A patent/AR081637A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2013527242A (ja) | 2013-06-27 |
EP2576585B1 (en) | 2016-10-12 |
US20120142707A1 (en) | 2012-06-07 |
ES2612452T3 (es) | 2017-05-17 |
EP2576585A1 (en) | 2013-04-10 |
EP2576585B8 (en) | 2016-12-21 |
EA201270780A1 (ru) | 2013-04-30 |
CN103038245B (zh) | 2015-03-25 |
CA2801487C (en) | 2017-12-05 |
US8754068B2 (en) | 2014-06-17 |
MX2012013703A (es) | 2012-12-17 |
JP5752789B2 (ja) | 2015-07-22 |
CA2801487A1 (en) | 2011-12-08 |
TW201201793A (en) | 2012-01-16 |
CN103038245A (zh) | 2013-04-10 |
WO2011153315A1 (en) | 2011-12-08 |
EA022393B1 (ru) | 2015-12-30 |
AR081637A1 (es) | 2012-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012030818A2 (pt) | "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv" | |
BR112012030810A2 (pt) | "c-28 amidas de derivados de ácido c-3 betulínico modificados como inibidores de maturação de hiv" | |
EA201391127A1 (ru) | C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич | |
BR112015019590A2 (pt) | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv | |
UY31673A1 (es) | "derivados heterocíclicos de urea y métodos de uso de los mismos-211" | |
MX2013004491A (es) | Boronatos como inhibidores de arginasa. | |
ECSP14006132A (es) | Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih | |
EA201170249A1 (ru) | 3,4-диарилпиразолы в качестве ингибиторов протеинкиназ | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
BR112014010105A2 (pt) | aminas de c-28 de derivados de ácido betulínico modificado por c-3 como inibidores de maturação de hiv | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
GT201200321A (es) | Derivados de heteroaril imidazolona como inhibidores de jak | |
UY31305A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen. | |
DOP2011000107A (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales | |
BR112014001665A2 (pt) | compostos de 2,3-di-hidroimidazo[1,2-c]pirimidin-5(1h)-ona utilizados como inibidores de lp-plaz | |
CL2015000039A1 (es) | Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis. | |
UY31864A (es) | Derivados de urea hetericíclica y métodos de uso de los mismos-332 | |
HN2011002578A (es) | Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad clucocorticoide. | |
CY1122596T1 (el) | Νεες φαρμακοτεχνικες μορφες (τριμεθοξυφαινυλαμινο)πυριμιδινυλιου | |
JOP20170029B1 (ar) | C-3 وc-17 تراي تربينويد معدلة كمثبطات لـhiv-1 | |
DOP2006000257A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
BR112017009850A2 (pt) | composto, composição, e, uso de uma quantidade melhoradora de hiv de um composto | |
UY32154A (es) | Derivados de isoquinolinona, procesos para su preparacion, composiciones farmaceuticas que los contiene y su uso en terapia | |
PH12018501640A1 (en) | C-3 and c-17 modified triterpenoids as hiv-1 inhibitors | |
BR112017009852A2 (pt) | composto, composição, e, usos de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |